Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
中国石油股份
00857
5
中国石油化工股份
00386
澳洲市场个股详情
Amplia Therapeutics Ltd (ATXOA)
- 0.040
- -0.005-11.11%
延时20分钟行情未开盘 06/10 13:09 (悉尼)
2053.25万总市值0.00市盈率(静)
0.040最高价0.040最低价2.50万股成交量0.040今开0.045昨收1000.00成交额0.23052周最高0.01%换手率5.13亿总股本0.01752周最低--每股收益TTM1739.19万流通值0.230历史最高0.00市盈率(静)4.35亿流通股0.009历史最低--每股收益(静)0.00%振幅--股息TTM0.00市净率1股每手--股息率TTM
Amplia Therapeutics Ltd (ATXOA) 利润表
季报+年报
显示同比
| (FY)2026/03/30 | (FY)2025/03/30 | (FY)2024/03/30 | (FY)2023/03/30 | (FY)2022/03/30 | (FY)2021/03/30 | (FY)2020/03/30 | (FY)2019/03/30 | (FY)2018/03/30 | (FY)2017/03/30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 营业总收入 | ||||||||||
| 主营业务成本 | ||||||||||
| 毛利 | ||||||||||
| 营业费用 | 24.63%1,318.01万 | 17.21%1,057.57万 | 20.70%902.28万 | 32.85%747.53万 | 45.26%562.7万 | 71.60%387.37万 | 16.32%225.74万 | -60.93%194.07万 | -44.61%496.74万 | 22.66%896.88万 |
| 销售和管理费用 | 31.71%362.32万 | 2.27%275.09万 | 11.73%268.99万 | 41.87%240.75万 | 25.78%169.7万 | 27.07%134.92万 | -3.94%106.17万 | -22.59%110.52万 | -40.34%142.78万 | 62.15%239.31万 |
| -管理费用 | 31.71%362.32万 | 2.27%275.09万 | 11.73%268.99万 | 41.87%240.75万 | 25.78%169.7万 | 27.07%134.92万 | -3.94%106.17万 | -22.59%110.52万 | -40.34%142.78万 | 62.15%239.31万 |
| 研发费用 | 20.60%907.92万 | 29.70%752.86万 | 23.85%580.48万 | 24.25%468.69万 | 70.55%377.22万 | 106.39%221.18万 | 57.97%107.17万 | -80.14%67.84万 | -43.39%341.67万 | 27.18%603.61万 |
| 折旧摊销及损耗 | 7.61%9.21万 | -0.61%8.56万 | 17.42%8.61万 | 2,186.32%7.34万 | 377.53%3,209 | -16.10%672 | -49.62%801 | -92.11%1,590 | -45.44%2.02万 | -93.50%3.7万 |
| -折旧及摊销 | 7.61%9.21万 | -0.61%8.56万 | 17.42%8.61万 | 2,186.32%7.34万 | 377.53%3,209 | -16.10%672 | -49.62%801 | -92.11%1,590 | -45.44%2.02万 | -93.50%3.7万 |
| 其他营业费用 | 83.11%38.56万 | -52.36%21.06万 | 43.71%44.2万 | 98.89%30.75万 | -50.44%15.46万 | 153.22%31.2万 | -20.75%12.32万 | 51.40%15.55万 | -79.57%10.27万 | -3.63%50.26万 |
| 营业利润 | -24.63%-1,318.01万 | -17.21%-1,057.57万 | -20.70%-902.28万 | -32.85%-747.53万 | -45.26%-562.7万 | -71.60%-387.37万 | -16.32%-225.74万 | 60.93%-194.07万 | 44.61%-496.74万 | -22.66%-896.88万 |
| 营业外利息收入与支出净额 | 209.95%68.17万 | 230.15%21.99万 | 53.48%6.66万 | 8,228.46%4.34万 | -141.30%-534 | -65.20%1,293 | -81.68%3,716 | -24.79%2.03万 | -55.92%2.7万 | -17.60%6.12万 |
| 营业外利息收入 | 153.45%69.91万 | 90.10%27.58万 | 49.20%14.51万 | 15,687.99%9.73万 | -52.36%616 | -65.20%1,293 | -81.68%3,716 | -24.79%2.03万 | -55.92%2.7万 | -17.61%6.12万 |
| 营业外利息支出 | -68.91%1.74万 | -28.79%5.59万 | 45.75%7.85万 | 4,582.43%5.38万 | --1,150 | ---- | ---- | ---- | ---- | ---- |
| 其他净收入/费用 | 26.63%479.12万 | -15.03%378.37万 | 274.34%445.27万 | -40.03%118.95万 | 24.64%198.33万 | 4,549.08%159.12万 | -32.19%3.42万 | -92.15%5.05万 | -64.90%64.28万 | -20.20%183.13万 |
| 其他营业外收入（费用） | 26.63%479.12万 | -15.03%378.37万 | 274.34%445.27万 | -40.03%118.95万 | 24.64%198.33万 | 4,549.08%159.12万 | -32.19%3.42万 | -92.15%5.05万 | -64.90%64.28万 | -20.20%183.13万 |
| 税前利润 | -17.27%-770.72万 | -45.93%-657.2万 | 27.86%-450.35万 | -71.30%-624.24万 | -59.76%-364.42万 | -2.79%-228.1万 | -18.66%-221.9万 | 56.49%-187万 | 39.26%-429.8万 | -43.15%-707.6万 |
| 所得税 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 除税后的权益收益 | ||||||||||
| 除税后利润 | -17.27%-770.72万 | -45.93%-657.2万 | 27.86%-450.35万 | -71.30%-624.24万 | -59.76%-364.42万 | -2.79%-228.1万 | -18.66%-221.9万 | 56.49%-187万 | 39.26%-429.8万 | -43.15%-707.6万 |
| 持续经营利润 | -17.27%-770.72万 | -45.93%-657.2万 | 27.86%-450.35万 | -71.30%-624.24万 | -59.76%-364.42万 | -2.79%-228.1万 | -18.66%-221.9万 | 56.49%-187万 | 39.26%-429.8万 | -43.15%-707.6万 |
| 归属于少数股东的净利润 | ||||||||||
| 归属于母公司的净利润 | -17.27%-770.72万 | -45.93%-657.2万 | 27.86%-450.35万 | -71.30%-624.24万 | -59.76%-364.42万 | -2.79%-228.1万 | -18.66%-221.9万 | 56.49%-187万 | 39.26%-429.8万 | -43.15%-707.6万 |
| 优先股派息 | ||||||||||
| 其他优先股派息 | ||||||||||
| 归属于普通股股东的净利润 | -17.27%-770.72万 | -45.93%-657.2万 | 27.86%-450.35万 | -71.30%-624.24万 | -59.76%-364.42万 | -2.79%-228.1万 | -18.66%-221.9万 | 56.49%-187万 | 39.26%-429.8万 | -43.15%-707.6万 |
| 基本每股收益 | ||||||||||
| 稀释每股收益 | ||||||||||
| 每股派息 | ||||||||||
| 会计准则 | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
